Theravance Biopharma, Inc. - TBPH
About Gravity Analytica
Recent News
- 06.02.2025 - Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million
- 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference
- 05.13.2025 - Theravance Biopharma to Participate in an Upcoming Investor Conference
- 05.09.2025 - Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress
Recent Filings
- 06.02.2025 - 8-K Current report
- 06.02.2025 - EX-99.1 EX-99.1
- 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.21.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.21.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.21.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.21.2025 - 4 Statement of changes in beneficial ownership of securities